ANDREW DINARDO to Antitubercular Agents
This is a "connection" page, showing publications ANDREW DINARDO has written about Antitubercular Agents.
Connection Strength
0.996
-
Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. Microbiol Spectr. 2026 Jan 06; 14(1):e0233525.
Score: 0.203
-
Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles. Lancet Microbe. 2024 09; 5(9):100869.
Score: 0.182
-
Tuberculosis endotypes to guide stratified host-directed therapy. Med. 2021 03 12; 2(3):217-232.
Score: 0.145
-
Perspective for Precision Medicine for Tuberculosis. Front Immunol. 2020; 11:566608.
Score: 0.142
-
Culture is an imperfect and heterogeneous reference standard in pediatric tuberculosis. Tuberculosis (Edinb). 2016 12; 101S:S105-S108.
Score: 0.108
-
Reactivation tuberculosis: role of surveillance. Expert Rev Anti Infect Ther. 2016; 14(5):501-9.
Score: 0.102
-
Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 05 19; 14(1):52.
Score: 0.040
-
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. Eur Respir J. 2021 09; 58(3).
Score: 0.038
-
Tuberculosis prevention in children: a prospective community-based study in South Africa. Eur Respir J. 2021 04; 57(4).
Score: 0.037